Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy
- PMID: 17361345
- PMCID: PMC2779375
- DOI: 10.1007/s00415-006-0432-4
Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy
Abstract
Background: We recently reported a randomised controlled trial on the efficacy of strength training and the beta2-adrenergic agonist albuterol in patients with facioscapulohumeral muscular dystrophy (FSHD). Strength training and albuterol appeared safe interventions with limited positive effect on muscle strength and volume. We concurrently explored the prevalence and the characteristics of pain and fatigue in the participating FSHD patients, because these are probably underreported but clinically relevant symptoms in this disorder. Next, we studied the effects of albuterol and strength training on pain, experienced fatigue, health-related functional status and psychological distress.
Methods: Sixty-five patients were randomised to strength training of elbow flexors and ankle dorsiflexors or non-training. After 26 weeks, albuterol (sustained-release, 8 mg bid) was added in a randomised, double-blind, placebo-controlled design. Outcomes comprised self-reported pain, experienced fatigue, functional status and psychological distress obtained with validated questionnaires at 52 weeks.
Results: Eighty percent of patients reported chronic persistent or periodic, multifocal pains. Thirty-four percent of the participants were severely fatigued. Strength training and albuterol failed to have a significant effect on all outcomes.
Conclusions: Pain and fatigue are important features in FSHD. Strength training and albuterol do not have a positive or negative effect on pain, experienced fatigue, functional status and psychological distress.
Figures
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/0003-9993(93)90031-5', 'is_inner': False, 'url': 'https://doi.org/10.1016/0003-9993(93)90031-5'}, {'type': 'PubMed', 'value': '8328892', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8328892/'}]}
- Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM (1993) Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 74:711–715 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9624661', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9624661/'}]}
- American College of Sports Medicine Position Stand (1998) The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 30:975–991 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00005768-200202000-00027', 'is_inner': False, 'url': 'https://doi.org/10.1097/00005768-200202000-00027'}, {'type': 'PubMed', 'value': '11828249', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11828249/'}]}
- American College of Sports Medicine Position Stand (2002) Progression models in resistance training for healthy adults. Med Sci Sports Exerc 34:364–380 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/mus.880181312', 'is_inner': False, 'url': 'https://doi.org/10.1002/mus.880181312'}, {'type': 'PubMed', 'value': '7739627', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7739627/'}]}
- Arahata K, Ishihara T, Fukunaga H, et al. (1995) Inflammatory response in facioscapulohumeral dystrophy (FSHD): immunocytochemical and genetic analysis. Muscle Nerve 2:S56–S66 - PubMed
-
- Arindell WA, Ettema JHM (1986) SCL- 90, handleiding bij multidimensionele psychopathologie-indicator. Swets & Zeitlinger BV, Amsterdam
